2000
DOI: 10.1128/iai.68.8.4752-4758.2000
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin-10 Gene Therapy-Mediated Amelioration of Bacterial Pneumonia

Abstract: Respiratory infection by Actinobacillus pleuropneumoniae causes a highly pathogenic necrotizing pleuropneumonia with severe edema, hemorrhage and fever. Acute infection is characterized by expression of inflammatory cytokines, including interleukin-1 (IL-1), IL-6 and IL-8. To determine if high level production of inflammatory cytokines contributed to disease pathogenesis, we investigated if inhibiting macrophage activation with adenovirus type 5-expressed IL-10 (Ad-5/IL-10) reduced the severity of acute diseas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
36
0
2

Year Published

2001
2001
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(39 citation statements)
references
References 34 publications
1
36
0
2
Order By: Relevance
“…In contrast to the above studies, Morrison et al [45] demonstrated that injection of a genetic construct capable of producing IL-10 into swine reduced the extent of A. pleuropneumoniae-induced pneumonia. This reduction was attributed to a concomitantly observed reduction in TNF-· and IL-1ß levels in lung lavage fluid.…”
Section: Discussionmentioning
confidence: 82%
“…In contrast to the above studies, Morrison et al [45] demonstrated that injection of a genetic construct capable of producing IL-10 into swine reduced the extent of A. pleuropneumoniae-induced pneumonia. This reduction was attributed to a concomitantly observed reduction in TNF-· and IL-1ß levels in lung lavage fluid.…”
Section: Discussionmentioning
confidence: 82%
“…11 In a porcine model of acute bacterial pneumonia, local expression of IL-10 suppressed lung edema and neutrophil invasion, resulting in significantly reduced lung damage. 29 These findings suggested that the protective role of IL-10 on the alveolar-capillary barrier is universal. However, the impact of systemic IL-10 is determined by the timing of application and the underlying disease, whereby in states of sterile inflammation it may be beneficial but deleterious in infection.…”
Section: Circulation Research February 14 2014mentioning
confidence: 80%
“…Although the role of IL-6 in the lung pathophysiology is still controversial since it may present pro-and anti-inflammatory effects, the functions of IL-10 offering clinical protection and reduction of lung pathology is well established (Morrison et al, 2000). Interleukin-10 reduces the levels and expression of TNF-␣ by mononuclear cells and mast cells (Weber et al, 1995).…”
Section: Discussionmentioning
confidence: 99%